Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E F JOHNSON

Showing results (1-10 of 127) with videos related to

Pageof 13
Sort By:
Journal of the National Medical Association|October 1, 1978
Look at it this way: some aspects of the drug mix-up problem among black, poor, aged, and female patientsE F Johnson
Trends in Pharmacological Sciences|March 1, 1992
Mapping determinants of the substrate selectivities of P450 enzymes by site-directed mutagenesisE F Johnson
American Journal of Pharmacy and the Sciences Supporting Public Health|October 29, 2010
Rutin and capillary fragilityE F JOHNSON
Health Services Reports|August 1, 1973
Modern implementation of Denmark's tradition of health care deliveryE F Johnson
The Journal of Biological Chemistry|January 10, 1980
Isolation and characterization of a constitutive form of rabbit liver microsomal cytochrome P-450E F Johnson
El Farmaceutico|October 29, 2010
Routine, a new drug to correct capillary fragilityE F JOHNSON
Science (New York, N.Y.)|May 17, 1991
A partnership between the dioxin receptor and a basic helix-loop-helix proteinE F Johnson
The Journal of Biological Chemistry|April 5, 1991
An inhibitory monoclonal antibody binds in close proximity to a determinant for substrate binding in cytochrome P450IIC5T Kronbach, E F Johnson
The Journal of Biological Chemistry|January 25, 2000
Engineering microsomal cytochrome P450 2C5 to be a soluble, monomeric enzyme. Mutations that alter aggregation, phospholipid dependence of catalysis, and membrane bindingJ Cosme, E F Johnson
Biochemical and Biophysical Research Communications|June 6, 1977
Purification of the major cytochrome P-450 of liver microsomes from rabbits treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)E F Johnson, U Muller-Eberhard
Pageof 13

Showing results (1-10 of 127) with videos related to

Sort By:
Pageof 13
Journal of the National Medical Association|October 1, 1978
Look at it this way: some aspects of the drug mix-up problem among black, poor, aged, and female patientsE F Johnson
Trends in Pharmacological Sciences|March 1, 1992
Mapping determinants of the substrate selectivities of P450 enzymes by site-directed mutagenesisE F Johnson
American Journal of Pharmacy and the Sciences Supporting Public Health|October 29, 2010
Rutin and capillary fragilityE F JOHNSON
Health Services Reports|August 1, 1973
Modern implementation of Denmark's tradition of health care deliveryE F Johnson
The Journal of Biological Chemistry|January 10, 1980
Isolation and characterization of a constitutive form of rabbit liver microsomal cytochrome P-450E F Johnson
El Farmaceutico|October 29, 2010
Routine, a new drug to correct capillary fragilityE F JOHNSON
Science (New York, N.Y.)|May 17, 1991
A partnership between the dioxin receptor and a basic helix-loop-helix proteinE F Johnson
The Journal of Biological Chemistry|April 5, 1991
An inhibitory monoclonal antibody binds in close proximity to a determinant for substrate binding in cytochrome P450IIC5T Kronbach, E F Johnson
The Journal of Biological Chemistry|January 25, 2000
Engineering microsomal cytochrome P450 2C5 to be a soluble, monomeric enzyme. Mutations that alter aggregation, phospholipid dependence of catalysis, and membrane bindingJ Cosme, E F Johnson
Biochemical and Biophysical Research Communications|June 6, 1977
Purification of the major cytochrome P-450 of liver microsomes from rabbits treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)E F Johnson, U Muller-Eberhard
Pageof 13